BRPI0406884A - Derivados de diazepans úteis como inibidores de lfa - Google Patents

Derivados de diazepans úteis como inibidores de lfa

Info

Publication number
BRPI0406884A
BRPI0406884A BR0406884-0A BRPI0406884A BRPI0406884A BR PI0406884 A BRPI0406884 A BR PI0406884A BR PI0406884 A BRPI0406884 A BR PI0406884A BR PI0406884 A BRPI0406884 A BR PI0406884A
Authority
BR
Brazil
Prior art keywords
lfa
diazepans
inhibitors
derivatives useful
icam
Prior art date
Application number
BR0406884-0A
Other languages
English (en)
Inventor
Berndt Oberhauser
Gottfried Meingassner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0301561A external-priority patent/GB0301561D0/en
Priority claimed from GB0323976A external-priority patent/GB0323976D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0406884A publication Critical patent/BRPI0406884A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"DERIVADOS DE DIAZEPANS úTEIS COMO INIBIDORES DE LFA". A presente invenção refere-se a diazepans farmaceuticamente ativos, por exemplo, úteis para o tratamento de distúrbios ou doenças mediadas por interações de LFA-1/ICAM-1, LFA-1/ICAM-2, LFA-1/ICAM-3 ou LFA1/JAM-1.
BR0406884-0A 2003-01-23 2004-01-22 Derivados de diazepans úteis como inibidores de lfa BRPI0406884A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0301561A GB0301561D0 (en) 2003-01-23 2003-01-23 Organic compounds
GB0323976A GB0323976D0 (en) 2003-10-13 2003-10-13 Organic compounds
PCT/EP2004/000514 WO2004065382A1 (en) 2003-01-23 2004-01-22 Diazepanes derivatives useful as lfa inhibitors

Publications (1)

Publication Number Publication Date
BRPI0406884A true BRPI0406884A (pt) 2006-01-03

Family

ID=32773971

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406884-0A BRPI0406884A (pt) 2003-01-23 2004-01-22 Derivados de diazepans úteis como inibidores de lfa

Country Status (19)

Country Link
US (1) US7419976B2 (pt)
EP (1) EP1590342A1 (pt)
JP (1) JP4644655B2 (pt)
KR (1) KR20050095618A (pt)
AR (1) AR042740A1 (pt)
AU (1) AU2004205504B2 (pt)
BR (1) BRPI0406884A (pt)
CA (1) CA2509764A1 (pt)
CO (1) CO5580804A2 (pt)
EC (1) ECSP055917A (pt)
MX (1) MXPA05007846A (pt)
MY (1) MY141850A (pt)
NO (1) NO20053911L (pt)
NZ (1) NZ540867A (pt)
PE (1) PE20040941A1 (pt)
PL (1) PL376540A1 (pt)
RU (1) RU2347783C2 (pt)
TW (1) TWI311557B (pt)
WO (1) WO2004065382A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059801A1 (ja) * 2004-12-02 2006-06-08 Asubio Pharma Co., Ltd. ７員環化合物並びにその製造法および医薬用途
GB0507918D0 (en) * 2005-04-19 2005-05-25 Novartis Ag Organic compounds
WO2010126968A1 (en) * 2009-04-28 2010-11-04 Optmed, Inc. Compositions and methods for treating or preventing urolithiasis and conditions associated therewith

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399599B1 (en) * 1999-10-13 2002-06-04 Novartis Ag Substituted 2-oxo-1,4-diazacycloalkanes
ECSP003707A (es) 1999-10-13 2002-05-23 Novartis Ag Diazepanes
AU776053B2 (en) * 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
PE20020420A1 (es) 2000-10-02 2002-06-27 Novartis Ag Derivados de diazacicloalcanodiona como antagonistas del antigeno asociado a la funcion del linfocito-1 (lfa-1)
NZ525573A (en) 2000-11-28 2005-08-26 Genentech Inc LFA-1 antagonist compounds

Also Published As

Publication number Publication date
TWI311557B (en) 2009-07-01
AR042740A1 (es) 2005-06-29
AU2004205504B2 (en) 2007-09-20
TW200418817A (en) 2004-10-01
RU2005126459A (ru) 2007-02-27
NZ540867A (en) 2007-09-28
EP1590342A1 (en) 2005-11-02
WO2004065382A1 (en) 2004-08-05
US7419976B2 (en) 2008-09-02
RU2347783C2 (ru) 2009-02-27
MY141850A (en) 2010-07-16
PE20040941A1 (es) 2005-01-24
US20060148780A1 (en) 2006-07-06
JP2006515335A (ja) 2006-05-25
ECSP055917A (es) 2005-11-22
NO20053911L (no) 2005-10-24
CA2509764A1 (en) 2004-08-05
KR20050095618A (ko) 2005-09-29
NO20053911D0 (no) 2005-08-22
JP4644655B2 (ja) 2011-03-02
CO5580804A2 (es) 2005-11-30
MXPA05007846A (es) 2006-02-10
PL376540A1 (pl) 2006-01-09
AU2004205504A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
UY27234A1 (es) Inhibidores novedosos de tirosina cinasa
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
BRPI0412347A (pt) 2-aminofenil-4-fenilpiridinas como inibidores de quinase
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
UY28011A1 (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
BR0312729A (pt) Novos derivados de indol-3-enxofre
CY1111070T1 (el) Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace)
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
ECSP056192A (es) 3-fluoro-piperidinas como antagonistas de nmda/nr2b
TW200800946A (en) Substituted piperazines as metabotropic glutamate receptor antagonists
CR8094A (es) Derivados de imidazol antagonistas del receptor de glutamato
BRPI0407913A (pt) antagonistas receptores de ccr-3
DOP2003000621A (es) Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
DOP2003000587A (es) AGONISTAS DEL RECEPTOR ß3-ADRENERGICO
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
BRPI0406884A (pt) Derivados de diazepans úteis como inibidores de lfa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal: dismissal of application maintained